The SalivaDirect™ Initiative, Yale School of Public Health
publichealth.yale.eduThe SalivaDirect Initiative at Yale School of Public Health advances its open-source PCR protocol to support partners with readily deployable, equitable testing solutions for sensitive detection of SARS-CoV-2. To date, more than 180 CLIA laboratories have provided over 7.0M tests nationwide. SalivaDirect also has been independently validated internationally in 12 countries.
Read moreReach decision makers at The SalivaDirect™ Initiative, Yale School of Public Health
Free credit every month!
The SalivaDirect Initiative at Yale School of Public Health advances its open-source PCR protocol to support partners with readily deployable, equitable testing solutions for sensitive detection of SARS-CoV-2. To date, more than 180 CLIA laboratories have provided over 7.0M tests nationwide. SalivaDirect also has been independently validated internationally in 12 countries.
Read more
Country
State
Connecticut
City (Headquarters)
New Haven
Employees
11-50
Founded
2020
Estimated Revenue
$50,000,000 to $100,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Covid - 19 Operations Coordinator
Email ****** @****.comPhone (***) ****-****Community Liaison at the Yale School of Public Health
Email ****** @****.comPhone (***) ****-****Engagement and Access
Email ****** @****.comPhone (***) ****-****Salivadirect Research Associate
Email ****** @****.comPhone (***) ****-****
Technologies
(9)
